HIF1A and Hepatic fibrosis: These findings indicate that HIF-1α exhibits high expression levels in CCl4-induced liver fibrosis tissue, which is consistent with previous reports [30], while ACBA treatment can effectively reduced the HIF-1α expression in hepatic fibrosis tissue.